BioTechX, the company behind Europe’s largest congress on diagnostics, precision medicine, and digital transformation in healthcare, has closed a $45.0M Series B funding round.
The capital infusion will support its efforts to accelerate the integration of genomics and big data innovations into clinical practice, a mission it advances by bringing together experts from genomics, translational medicine, and pharma companies at its annual events. BioTechX Europe, held annually in Basel since 2018, is a prominent fixture in the industry calendar.











.png&w=3840&q=75)



